锦波生物
(920982)
| 流通市值：131.66亿 | | | 总市值：275.93亿 |
| 流通股本：5490.51万 | | | 总股本：1.15亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 879,718,384.53 | 912,280,324.91 | 958,678,503.23 | 941,124,763.4 |
| 应收票据及应收账款 | 323,767,081.65 | 256,804,822.69 | 169,525,276.77 | 189,452,905.91 |
| 其中：应收票据 | 9,500,000 | 42,105,000 | 15,393,000 | 5,835,000 |
| 应收账款 | 314,267,081.65 | 214,699,822.69 | 154,132,276.77 | 183,617,905.91 |
| 应收款项融资 | - | 28,324,000 | 23,450,000 | 5,139,000 |
| 预付款项 | 36,096,556.8 | 40,817,543.52 | 43,112,092.7 | 38,149,612.05 |
| 其他应收款合计 | 7,373,589.16 | 7,743,263.84 | 7,984,389.09 | 9,052,787.52 |
| 存货 | 162,455,625.83 | 153,233,415.36 | 117,791,431.68 | 96,567,880.45 |
| 其他流动资产 | 7,847,013.67 | 7,914,283.89 | 9,891,894.55 | 18,120,974.31 |
| 流动资产合计 | 1,417,258,251.64 | 1,407,117,654.21 | 1,330,433,588.02 | 1,297,607,923.64 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 30,000,000 | - | - | - |
| 固定资产 | 438,440,286.38 | 446,343,540.08 | 449,648,127.59 | 460,452,397.97 |
| 在建工程 | 227,498,431.52 | 188,087,300.46 | 141,432,529.28 | 19,373,344.59 |
| 使用权资产 | 84,595,983.16 | 82,979,139.25 | 86,823,582.58 | 90,668,025.91 |
| 无形资产 | 119,211,861.33 | 127,233,123.89 | 120,579,766.03 | 22,534,870.15 |
| 开发支出 | 87,004,261.41 | 58,845,193.42 | 73,615,602.43 | 69,941,527.85 |
| 长期待摊费用 | 16,851,474.52 | 17,782,921.92 | 18,754,117.03 | 19,436,340.05 |
| 递延所得税资产 | 19,191,651.28 | 16,844,667.73 | 14,976,479.99 | 14,666,317.02 |
| 其他非流动资产 | 22,174,654.05 | 21,709,188.08 | 23,098,206.84 | 61,392,669.8 |
| 非流动资产合计 | 1,044,968,603.65 | 959,825,074.83 | 928,928,411.77 | 758,465,493.34 |
| 资产总计 | 2,462,226,855.29 | 2,366,942,729.04 | 2,259,361,999.79 | 2,056,073,416.98 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 116,629,357.54 | 107,926,990.26 | 91,389,278.91 | 51,533,951.96 |
| 应付账款 | 116,629,357.54 | 107,926,990.26 | 91,389,278.91 | 51,533,951.96 |
| 合同负债 | 59,251,385.26 | 55,933,147.72 | 49,541,123.53 | 42,588,204.89 |
| 应付职工薪酬 | 33,099,262.92 | 35,477,986.8 | 31,669,296.88 | 49,787,597.02 |
| 应交税费 | 82,822,062.19 | 85,615,064.18 | 62,024,074.01 | 52,299,445.28 |
| 其他应付款合计 | 92,699,881.59 | 81,354,163.17 | 27,620,299.03 | 25,463,945.85 |
| 一年内到期的非流动负债 | 31,088,862.29 | 26,917,859.33 | 59,427,489.67 | 63,847,868.24 |
| 其他流动负债 | 3,828,416.29 | 5,615,924.65 | 9,636,412.58 | 6,637,891.26 |
| 流动负债合计 | 419,419,228.08 | 398,841,136.11 | 331,307,974.61 | 292,158,904.5 |
| 非流动负债: | | | | |
| 长期借款 | 64,304,745.72 | 74,609,116.26 | 76,069,471.54 | 79,588,411.52 |
| 租赁负债 | 82,633,980.47 | 78,773,340.09 | 93,088,926.06 | 93,475,341.14 |
| 递延收益 | 49,470,278.42 | 51,402,084.69 | 52,135,867.93 | 53,199,535.77 |
| 递延所得税负债 | 1,226,055.19 | 1,298,465.97 | 1,370,876.75 | 1,443,287.53 |
| 其他非流动负债 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 |
| 非流动负债合计 | 202,635,059.8 | 211,083,007.01 | 227,665,142.28 | 232,706,575.96 |
| 负债合计 | 622,054,287.88 | 609,924,143.12 | 558,973,116.89 | 524,865,480.46 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 115,065,340 | 115,065,340 | 88,511,800 | 88,511,800 |
| 资本公积 | 320,202,825.03 | 300,812,351.33 | 316,242,811.29 | 316,242,811.29 |
| 盈余公积 | 44,255,900 | 44,255,900 | 44,255,900 | 44,255,900 |
| 未分配利润 | 1,362,387,723.65 | 1,301,237,656.97 | 1,254,733,715.17 | 1,086,203,317.13 |
| 归属于母公司股东权益合计 | 1,841,911,788.68 | 1,761,371,248.3 | 1,703,744,226.46 | 1,535,213,828.42 |
| 少数股东权益 | -1,739,221.27 | -4,352,662.38 | -3,355,343.56 | -4,005,891.9 |
| 股东权益合计 | 1,840,172,567.41 | 1,757,018,585.92 | 1,700,388,882.9 | 1,531,207,936.52 |
| 负债和股东权益合计 | 2,462,226,855.29 | 2,366,942,729.04 | 2,259,361,999.79 | 2,056,073,416.98 |
| 公告日期 | 2025-10-29 | 2025-08-11 | 2025-04-22 | 2025-04-21 |
| 审计意见(境内) | | | | 标准无保留意见 |